Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Huan Jing Ke Xue ; 44(4): 2215-2222, 2023 Apr 08.
Artigo em Chinês | MEDLINE | ID: mdl-37040970

RESUMO

With the rapid development of urbanization in China, the number of gas stations in cities is increasing. The composition of oil products in gas stations is complex and diverse, and a series of pollutants will be generated in the process of oil diffusion. Polycyclic aromatic hydrocarbons (PAHs) produced by gas stations can pollute the nearby soil and affect human health. In this study, soil samples (0-20 cm) near 117 gas stations in Beijing were collected, and the contents of seven PAHs were analyzed. Based on the BP neural network model, the contents of PAHs in soil of Beijing gas stations in 2025 and 2030 were predicted. The results showed that the total concentrations of the seven PAHs were 0.01-3.53 mg·kg-1. The concentrations of PAHs were lower than the soil environmental quality risk control standard for soil contamination of development land (Trial) GB 36600-2018. At the same time, the toxic equivalent concentrations (TEQ) of the above seven PAHs were lower than the standard value (1 mg·kg-1) of the World Health Organization (WHO), which they indicate a lower risk to human health. The prediction results showed that the rapid development of urbanization had a positive correlation with the increase in soil PAHs content. By 2030, the content of PAHs in Beijing gas station soil will continue to grow. The predicted concentrations of PAHs in the soil of Beijing gas stations in 2025 and 2030 were 0.085-4.077 mg·kg-1and 0.132-4.412 mg·kg-1, respectively. The contents of seven PAHs were lower than the soil pollution risk screening value of GB 36600-2018; however, the concentration of PAHs increased over time.The contents of PAHs in Chaoyang, Fengtai, and Haidian were relatively higher, which requires further attention.

2.
Zhongguo Zhong Yao Za Zhi ; 38(3): 307-13, 2013 Feb.
Artigo em Chinês | MEDLINE | ID: mdl-23667999

RESUMO

Ginseng is one of traditional Chinese medicines widely used worldwide according to the theory that "food and medicine share the same origin". Its main active ingredients are believed to be ginsenoside. In the past decades, studies on their chemical structure and pharmacological activity have made significant progress. So far, however, there is not a specific describtion on ginseng preparation and in vivo conversion process as well as an explanation on why rare ginsenoside can enhance anticancer activity. Therefore, this essay first describes the diversity of ginsenoside contained in ginseng, including natural ginsenoside, special ginsenoside generated from preparation and bioconversion processes. Subsequently, it summarizes the preparation and in vitro conversion processes, and discusses the potential structure-activity relationship between rare ginsenoside and its pharmacological activity. The study on the correlation between these chemical changes and their pharmacological activity help bring forth new ideas to the enhancement of anticancer activity of ginsenoside, and facilitate the development of new anticancer drugs.


Assuntos
Ginsenosídeos/química , Ginsenosídeos/uso terapêutico , Neoplasias/tratamento farmacológico , Panax/química , Humanos , Modelos Químicos , Estrutura Molecular , Fitoterapia , Relação Estrutura-Atividade
3.
Clin Exp Pharmacol Physiol ; 30(3): 185-8, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12603349

RESUMO

1. The present study found that, compared with mouse heart and liver, P388 ascitic tumour had significantly lower superoxide dismutase (SOD) activity and that compared with the mouse liver, the heart had significantly lower SOD and catalase activities, as well as a lower glutathione content. 2. At 7.5 mg/kg, doxorubicin (DOX), a superoxide radical inducer, induced significant lipid peroxidation only in the tumour, whereas 15.0 mg/kg DOX induced lipid peroxidation in both the tumour and heart, but not in the liver. 3. Overall, the results of the present study suggest that the differential anti-oxidant activities in P388 ascitic tumour, heart and liver in mice may explain their differential responses and, hence, susceptibility to DOX-induced lipid peroxidation.


Assuntos
Antioxidantes/farmacologia , Doxorrubicina/farmacologia , Leucemia P388/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Miocárdio/metabolismo , Animais , Peroxidação de Lipídeos/fisiologia , Camundongos , Camundongos Endogâmicos DBA , Ensaios Antitumorais Modelo de Xenoenxerto/métodos
4.
Lipids ; 37(6): 549-56, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12120952

RESUMO

In this study, four kinds of rodent diets, CO, FO, CVe, and FVe, were used by addition of canola oil, oil mixture (fish oil + canola oil), canola oil plus vitamin E, and oil mixture plus vitamin E, respectively, to a basic diet, AIN-93G, to investigate the influence of dietary fish oil and vitamin E on doxorubicin (DOX) treatment in P388 ascitic mice. Animal life span (LS) and heart damage were recorded in mice fed the four different diets and treated with different doses of DOX. The optimal doses of DOX for antitumor effect as manifested by increased LS were 6.0 and 9.0 mg/kg. Both fish oil and vitamin E significantly enhanced this effect. On the other hand, DOX at 12.0 mg/kg induced severe heart damage, which was also significantly aggravated by both fish oil and vitamin E, as shown by both decreased LS and increased serum creatine phosphokinase activity. Fish oil and vitamin E appeared to enhance the antitumor effect of optimal doses of DOX but to aggravate cardiotoxicity owing to DOX overdose.


Assuntos
Gorduras Insaturadas na Dieta/farmacologia , Doxorrubicina/farmacologia , Óleos de Peixe/farmacologia , Leucemia P388/patologia , Vitamina E/farmacologia , Animais , Ascite/patologia , Creatina Quinase/biossíntese , Doxorrubicina/efeitos adversos , Sinergismo Farmacológico , Indução Enzimática , Coração/efeitos dos fármacos , Leucemia P388/enzimologia , Camundongos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA